Invesco Bloomberg Analyst Rating Improvers ETF Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison

Buy

63

UPGD
Invesco Bloomberg Analyst Rating Improvers ETF

Last Price:

$76.72

Seasonality Move:

5.42%

Buy

65

RGC
Regencell Bioscience Holdings Ltd.

Last Price:

$49.05

Seasonality Move:

97.02%

Buy

63

Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is a Buy

Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?

The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $76.19. The Score for UPGD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
UPGD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

65

Regencell Bioscience Holdings Ltd. (RGC) is a Buy

Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?

The current Regencell Bioscience Holdings Ltd. [RGC] share price is $41.42. The Score for RGC is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPGD Stock Price Chart

What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?

The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $76.19

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGC Stock Price Chart

What is Regencell Bioscience Holdings Ltd.'s stock price today?

The Regencell Bioscience Holdings Ltd. share price today is $41.42

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.

UPGD Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	19.1	Buy
Relative Strength Index (14 RSI):	59.37	Buy
Chaikin Money Flow:	746	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(74.59 - 75.93)	Buy
Bollinger Bands (100):	(73.37 - 75.51)	Buy

RGC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.89	Buy
Relative Strength Index (14 RSI):	67.99	Buy
Chaikin Money Flow:	-1949190	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.46 - 30.82)	Buy
Bollinger Bands (100):	(10.82 - 22.22)	Buy

UPGD Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	75.03	Buy
20-day SMA:	75.39	Buy
50-day SMA:	74.31	Buy
200-day SMA:	72.22	Buy
8-day EMA:	72.42	Buy
20-day EMA:	54.75	Buy
50-day EMA:	30.51	Buy
200-day EMA:	9.17	Buy

RGC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	30.29	Buy
20-day SMA:	23.74	Buy
50-day SMA:	17.76	Buy
200-day SMA:	14.47	Buy
8-day EMA:	33.46	Buy
20-day EMA:	26.08	Buy
50-day EMA:	20.45	Buy
200-day EMA:	14.25	Buy

Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis

	Dec 22	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7	Jan 8
	Dec							Jan
	22	24	26	29	30	31	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regencell Bioscience Holdings Ltd. Technical Analysis

	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 2	Jan 5	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	29	30	31	02	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):